Safety and Anti-Inflammatory Effects of Engineered Extracellular Vesicles (ILB-202) for NF-κB Inhibition: A Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial
J. Extracell. Vesicles, Sep 2025, 14 (9) e70141 | https://doi.org/10.1002/jev2.70141
